Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $5.31M | ﹤0.01% |
200,000
| – | – |
|
1302
Agree Realty
ADC
$9.41B
| $5.29M | ﹤0.01% |
80,964
-20,576
| -20% | -$1.36M |
|
|
NUVA
1303
DELISTED
NuVasive, Inc.
NUVA
| $5.29M | ﹤0.01% |
127,283
+15,631
| +14% | +$642K |
|
1304
Neogen
NEOG
$2.5B
| $5.29M | ﹤0.01% |
243,383
+109,221
| +81% | +$1.97M |
|
1305
NNN REIT
NNN
$8.99B
| $5.26M | ﹤0.01% |
123,035
-47,768
| -28% | -$2.06M |
|
1306
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $5.24M | ﹤0.01% |
+160,000
| New | +$5.39M |
|
1307
Ashland
ASH
$3.5B
| $5.22M | ﹤0.01% |
60,031
+49,250
| +457% | +$4.55M |
|
1308
Helmerich & Payne
HP
$3.71B
| $5.21M | ﹤0.01% |
146,923
+15,276
| +12% | +$521K |
|
1309
Brookfield Renewable
BEPC
$6.26B
| $5.2M | ﹤0.01% |
164,843
-41,294
| -20% | -$1.39M |
|
1310
iShares Select Dividend ETF
DVY
$23.6B
| $5.18M | ﹤0.01% |
+45,696
| New | +$5.21M |
|
1311
Expro Ltd
XPRO
$1.91B
| $5.15M | ﹤0.01% |
290,626
-12,752
| -4% | -$230K |
|
1312
Box
BOX
$4.6B
| $5.13M | ﹤0.01% |
174,614
-9,658
| -5% | -$267K |
|
1313
First Interstate BancSystem
FIBK
$3.58B
| $5.12M | ﹤0.01% |
214,930
+100,295
| +87% | +$2.53M |
|
1314
CALL
Accenture
ACN
$108B
| $5.12M | ﹤0.01% |
+16,600
| New | +$4.82M |
|
1315
CALL
Target
TGT
$68B
| $5.12M | ﹤0.01% |
38,800
-17,200
| -31% | -$2.55M |
|
1316
TD Synnex
SNX
$20.2B
| $5.11M | ﹤0.01% |
54,403
+16,255
| +43% | +$1.49M |
|
1317
Chemours
CC
$2.37B
| $5.1M | ﹤0.01% |
138,323
+61,143
| +79% | +$1.87M |
|
|
FOLD
1318
DELISTED
Amicus Therapeutics
FOLD
| $5.09M | ﹤0.01% |
405,340
-51,810
| -11% | -$615K |
|
1319
Vaxcyte
PCVX
$8.64B
| $5.07M | ﹤0.01% |
101,508
+9,303
| +10% | +$441K |
|
1320
Nu Holdings
NU
$66.9B
| $5.06M | ﹤0.01% |
641,068
+45,872
| +8% | +$282K |
|
1321
TXO Partners LP
TXO
$760M
| $5.06M | ﹤0.01% |
233,565
+4,107
| +2% | +$91.3K |
|
1322
BJs Wholesale Club
BJ
$12.3B
| $5.04M | ﹤0.01% |
80,013
+34,707
| +77% | +$2.4M |
|
|
IMGN
1323
DELISTED
Immunogen Inc
IMGN
| $5.03M | ﹤0.01% |
266,542
-584,193
| -69% | -$6.9M |
|
|
ABCM
1324
DELISTED
Abcam PLC
ABCM
| $5.02M | ﹤0.01% |
205,295
+197,735
| +2,616% | +$3.41M |
|
1325
Axcelis
ACLS
$4.31B
| $5.02M | ﹤0.01% |
27,356
-8,554
| -24% | -$1.23M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.